Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annales De Pathologie|February 6, 2018
[Ovarian Sertoli-Leydig tumor: A tricky tumor]Nicolas Brandone, Claude Borrione, Angélique Rome, et al.
Annales De Pathologie|March 21, 2016
[The colloid milium: An observation associated with trichinosis]Ilona Okhremchuk, Safia Abed, Anh Tuan Nguyen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 7, 2019
Validation of the QR1 Antibody for the Evaluation of PD-L1 Expression in Non-Small Cell Lung AdenocarcinomasNicolas Brandone, Céline Mascaux, Kevin Caselles, et al.
Annales De Pathologie|March 21, 2016
[A solid variant of a serous cystadenocarcinoma of the pancreas]Nicolas Brandone, Flora Poizat, Jeanne Thomassin-Piana, et al.
Annales De Pathologie|November 25, 2017
[An ovarian tumor can hide another one]Nicolas Brandone, Ilona Okhremchuk, Marie-Christine Rojat-Habib, et al.
Frontiers in Oncology|June 25, 2019
Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)Benjamin Bian, Natalia Anahi Juiz, Odile Gayet, et al.
BJU International|September 13, 2016
Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real-life experienceNicolas Branger, Thomas Maubon, Miriam Traumann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2019
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)Arnaud Jeanson, Pascale Tomasini, Maxime Souquet-Bressand, et al.
Ebiomedicine|May 27, 2023
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancerFrançois Ghiringhelli, Frederic Bibeau, Laurent Greillier, et al.
Ebiomedicine|July 7, 2020
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancerRémy Nicolle, Yuna Blum, Pauline Duconseil, et al.
Pageof 1